| (Values in U.S. Thousands) | Sep, 2023 | Sep, 2022 | Sep, 2021 | Sep, 2020 | Sep, 2019 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | -1,950 | -1,490 | -9,800 | -540 | -680 |
| Net Income Growth | -30.87% | +84.80% | -1,714.81% | +20.59% | +17.07% |
Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
GlobeStar Therapeutics Corporation is focused on providing medical research, development and treatments for wellness and disease. GlobeStar Therapeutics Corporation, formerly known as AngioSoma Inc., is based in RICHLAND, WA.
Fiscal Year End Date: 09/30